First Time Loading...

BIOLASE Inc
NASDAQ:BIOL

Watchlist Manager
BIOLASE Inc Logo
BIOLASE Inc
NASDAQ:BIOL
Watchlist
Price: 0.1768 USD 21.85% Market Closed
Updated: May 7, 2024

BIOLASE Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

BIOLASE Inc
Cash from Operating Activities Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
BIOLASE Inc
NASDAQ:BIOL
Cash from Operating Activities
-$14.1m
CAGR 3-Years
-3%
CAGR 5-Years
0%
CAGR 10-Years
-4%
Becton Dickinson and Co
NYSE:BDX
Cash from Operating Activities
$3.4B
CAGR 3-Years
-8%
CAGR 5-Years
4%
CAGR 10-Years
8%
Boston Scientific Corp
NYSE:BSX
Cash from Operating Activities
$2.5B
CAGR 3-Years
10%
CAGR 5-Years
40%
CAGR 10-Years
8%
Stryker Corp
NYSE:SYK
Cash from Operating Activities
$3.5B
CAGR 3-Years
3%
CAGR 5-Years
6%
CAGR 10-Years
6%
Abbott Laboratories
NYSE:ABT
Cash from Operating Activities
$7.1B
CAGR 3-Years
-10%
CAGR 5-Years
4%
CAGR 10-Years
8%
Intuitive Surgical Inc
NASDAQ:ISRG
Cash from Operating Activities
$1.7B
CAGR 3-Years
2%
CAGR 5-Years
7%
CAGR 10-Years
8%

See Also

What is BIOLASE Inc's Cash from Operating Activities?
Cash from Operating Activities
-14.1m USD

Based on the financial report for Dec 31, 2023, BIOLASE Inc's Cash from Operating Activities amounts to -14.1m USD.

What is BIOLASE Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
-4%

Over the last year, the Cash from Operating Activities growth was 47%. The average annual Cash from Operating Activities growth rates for BIOLASE Inc have been -3% over the past three years , and -4% over the past ten years .